Shihong Ma

1.5k total citations
40 papers, 1.1k citations indexed

About

Shihong Ma is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shihong Ma has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shihong Ma's work include Thyroid Cancer Diagnosis and Treatment (8 papers), Asymmetric Synthesis and Catalysis (4 papers) and Prostate Cancer Treatment and Research (4 papers). Shihong Ma is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (8 papers), Asymmetric Synthesis and Catalysis (4 papers) and Prostate Cancer Treatment and Research (4 papers). Shihong Ma collaborates with scholars based in China, United States and Canada. Shihong Ma's co-authors include R. G. Cutler, Vincent L. Wilson, Ruth A. Smith, Mark Lautens, Pauline Chiu, Ganesh V. Raj, Tomislav Rovis, Yi Yin, Rui Li and Miao Lu and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Shihong Ma

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shihong Ma China 15 528 266 144 131 124 40 1.1k
Abhi Veerakumarasivam Malaysia 23 724 1.4× 232 0.9× 109 0.8× 161 1.2× 84 0.7× 53 1.3k
Gabriele E. Lang Germany 28 701 1.3× 122 0.5× 94 0.7× 62 0.5× 63 0.5× 140 3.6k
Ingrid Wagner Germany 23 854 1.6× 225 0.8× 164 1.1× 228 1.7× 75 0.6× 65 2.4k
Anqi Chen China 20 640 1.2× 322 1.2× 92 0.6× 177 1.4× 54 0.4× 57 1.1k
Kazuki Sakata Japan 18 272 0.5× 303 1.1× 44 0.3× 148 1.1× 89 0.7× 82 1.3k
Erica J. Peterson United States 19 759 1.4× 264 1.0× 68 0.5× 67 0.5× 30 0.2× 35 1.2k
Ivan Grishagin United States 11 348 0.7× 110 0.4× 44 0.3× 75 0.6× 103 0.8× 16 808
Michio Fujie Japan 26 803 1.5× 119 0.4× 70 0.5× 451 3.4× 168 1.4× 61 1.7k
Christopher R. Smith United Kingdom 23 832 1.6× 161 0.6× 204 1.4× 241 1.8× 161 1.3× 62 1.7k
Sunil Kumar India 18 484 0.9× 177 0.7× 47 0.3× 39 0.3× 44 0.4× 97 1.2k

Countries citing papers authored by Shihong Ma

Since Specialization
Citations

This map shows the geographic impact of Shihong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shihong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shihong Ma more than expected).

Fields of papers citing papers by Shihong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shihong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shihong Ma. The network helps show where Shihong Ma may publish in the future.

Co-authorship network of co-authors of Shihong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Shihong Ma. A scholar is included among the top collaborators of Shihong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shihong Ma. Shihong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Shihong, Tianyi Ma, Jiahao Liu, et al.. (2025). PsyScam: A Benchmark for Psychological Techniques in Real-World Scams. 12623–12637.
2.
Roggero, Carlos M., et al.. (2024). CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer. Translational Oncology. 52. 102231–102231. 3 indexed citations
3.
Chu, Qianqian, et al.. (2023). Knockdown of Programmed Death 1 Inhibited Progression of PapillaryThyroid Carcinoma in Mice. Protein and Peptide Letters. 30(5). 396–400. 2 indexed citations
4.
Roggero, Carlos M., Victoria Esser, Lingling Duan, et al.. (2022). Poly-glutamine-dependent self-association as a potential mechanism for regulation of androgen receptor activity. PLoS ONE. 17(1). e0258876–e0258876. 7 indexed citations
5.
Guan, Bing, Ning Zhou, Cheng‐Yang Wu, et al.. (2021). Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer. International Journal of Molecular Sciences. 22(23). 13085–13085. 11 indexed citations
6.
7.
Kollipara, Rahul K., Rajni Sonavane, Xiaofang Huo, et al.. (2020). Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer. Cancer Letters. 488. 40–49. 15 indexed citations
8.
Ma, Shihong, et al.. (2020). PD-L1, PDK-1 and p-Akt are correlated in patients with papillary thyroid carcinoma. Advances in Clinical and Experimental Medicine. 29(7). 785–792. 4 indexed citations
9.
Ma, Shihong, James A. Richardson, Andrew BitMansour, et al.. (2013). Partial Depletion of Regulatory T Cells Does Not Influence the Inflammation Caused by High Dose Hemi-Body Irradiation. PLoS ONE. 8(2). e56607–e56607. 8 indexed citations
10.
Ma, Shihong, et al.. (2013). Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation.. PubMed. 2(3). 187–96. 79 indexed citations
11.
Lü, Shuai, et al.. (2012). Upregulation of microRNA-224 confers a poor prognosis in glioma patients. Clinical & Translational Oncology. 15(7). 569–574. 30 indexed citations
12.
Sun, Yan, Yi‐Long Wu, Caicun Zhou, et al.. (2012). Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: A randomized, open-label study. Lung Cancer. 79(2). 143–150. 29 indexed citations
13.
Ma, Shihong, George G. Chen, Caiguo Ye, et al.. (2010). Susceptibility of Hep3B cells in different phases of cell cycle to tBid. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1813(1). 179–185. 1 indexed citations
14.
Ma, Shihong, Li Zheng, Yingjie Liu, et al.. (2007). Plasmodium yoelii: Influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice. Experimental Parasitology. 116(3). 266–272. 14 indexed citations
15.
Wu, Yi, Qinghui Wang, Zheng Li, et al.. (2006). Plasmodium yoelii: Distinct CD4+CD25+ regulatory T cell responses during the early stages of infection in susceptible and resistant mice. Experimental Parasitology. 115(3). 301–304. 53 indexed citations
16.
Ma, Shihong, Dmitry M. Rudkevich, & Julius Rebek. (1999). Supramolekulare Isomerie in Caviplexen. Angewandte Chemie. 111(17). 2761–2764. 9 indexed citations
17.
Lautens, Mark, Shihong Ma, & Pauline Chiu. (1997). Synthesis of Cyclohexenols and Cycloheptenols via the Regioselective Reductive Ring Opening of Oxabicyclic Compounds. Journal of the American Chemical Society. 119(28). 6478–6487. 28 indexed citations
18.
Lautens, Mark & Shihong Ma. (1996). Nickel-Catalyzed Addition of Grignard Reagents to Oxabicyclic Compounds. Ring-Opening Reactions with Previously Unreactive Substrates and Nucleophiles. The Journal of Organic Chemistry. 61(21). 7246–7247. 38 indexed citations
19.
Lautens, Mark, Pauline Chiu, Shihong Ma, & Tomislav Rovis. (1995). Nickel-Catalyzed Hydroalumination of Oxabicyclic Alkenes. Ligand Effects on the Regio- and Enantioselectivity. Journal of the American Chemical Society. 117(1). 532–533. 80 indexed citations
20.
Wilson, Vincent L., Ruth A. Smith, Shihong Ma, & R. G. Cutler. (1987). Genomic 5-methyldeoxycytidine decreases with age.. Journal of Biological Chemistry. 262(21). 9948–9951. 407 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abhi Veerakumarasivam Breakdown of academic impact, for papers by Gabriele E. Lang Breakdown of academic impact, for papers by Ingrid Wagner Breakdown of academic impact, for papers by Anqi Chen Breakdown of academic impact, for papers by Kazuki Sakata Breakdown of academic impact, for papers by Erica J. Peterson Breakdown of academic impact, for papers by Ivan Grishagin Breakdown of academic impact, for papers by Michio Fujie Breakdown of academic impact, for papers by Christopher R. Smith Breakdown of academic impact, for papers by Sunil Kumar
Rankless by CCL
2026